This site contains promotional information intended only for healthcare professionals resident in Great Britain
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Identifying Those at Increased Risk of Pneumococcal Pneumonia
Pneumonia can be caused by bacteria, viruses and fungi1. Streptococcus pneumoniae is the most common bacterial cause1.
Adults can choose to pay privately to receive APEXXNAR in the UK to help protect themselves from invasive disease and pneumonia caused by Streptococcus pneumoniae2.
APEXXNAR can be administered privately at any time of year2.
Alternative pneumococcal vaccines are available as part of the UK National Immunisation Programme for specific patient cohorts at increased risk of serious illness3.
This includes; babies, adults aged 65 years and older, and children and adults with specific long-term health conditions3.
Pneumonia can affect people of any age1. However, many factors can put adults at increased risk of pneumococcal infections, including pneumococcal pneumonia, making them potential candidates for private vaccination1,4-13.
Those who might be at increased risk include:
*Risk data above is for people aged 50-64. People aged 18-49 had lower risk ratios and people 65 years and older had higher ratios.
Watch these videos to learn more about how these chronic conditions can be risk factors for pneumococcal disease.
Learn about how chronic heart disease can be a risk factor for pneumococcal disease in this three and a half minute video12.
This four minute video informs about how chronic respiratory disease can be a risk factor for pneumococcal disease12.
A diagnosis of diabetes is a risk factor for pneumococcal disease12. Learn more in this three minute video.
Opportunities to identify candidates for private vaccination services can occur all year round.
Explore our content to learn more about APEXXNAR.
20-valent pneumococcal conjugate vaccine for adults that helps protect against pneumococcal disease originating from vaccine-type serotypes2,14
Find out about the composition of conjugate vaccines2
Key information about dosing, administration and storage of APEXXNAR2
References:
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024